Clinical trial
Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of…
NCT00185198 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185198 |
|---|---|
| Title | Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM) |
| Official title | Multicenter, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone 50-100mg) to Evaluate Its Efficacy and Safety in Men Presenting With Typical Symptoms of Partial Androgen Deficiency of Aging Males (PADAM) Over a Period of 6 Months With 12 Months Open Label Follow-up |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Androgens (Deficiency), Male |
| Intervention type | Drug |
| Interventions | Testogel (Testosterone, BAYV001915), Placebo |
| Enrollment | 363 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 2, 2014 |
| Countries | Austria, Finland, Germany, Ireland, Italy, Spain, Sweden, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: